Announced Thu, 2 Jul · 13:21 IST
Routine compliance certificate for share dematerialization filed
Compliance View source PDF
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹978.00
prior close
₹975.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.0-0.0-0.1-0.8+0.6+0.4-0.6-0.5-0.6-0.5———
Up moveDown movePending
AI summary
Jubilant Pharmova submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The certificate, issued by Registrar Alankit Assignments, confirms that physical share certificates received for dematerialization were listed on exchanges, verified, cancelled, and the depository was recorded as the registered owner. This is a routine quarterly compliance filing with no business impact.
Likely market impact
No impact on shareholders or stock price; routine procedural regulatory filing.